Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy

Documenti analoghi

• Exploring the factors affecting the occurrence of postoperative MVI and the prognosis of hepatocellular carcinoma patients treated with hepatectomy: A multicenter retrospective study
  di: Jilin Yang, et al.
  Pubblicazione: (2024)
• A clinical‐radiomic‐pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resection
  di: Qu Xie, et al.
  Pubblicazione: (2024)
• Radiotherapy and chemoradiotherapy for postoperative recurrence in patients with esophageal squamous cell carcinoma
  di: Qing Liu, et al.
  Pubblicazione: (2024)
• Association of serum AFP trajectories and hepatocellular carcinoma outcomes after hepatic arterial infusion chemotherapy: A longitudinal, multicenter study
  di: Chao An, et al.
  Pubblicazione: (2024)
• The m6A methyltransferase METTL5 promotes neutrophil extracellular trap network release to regulate hepatocellular carcinoma progression
  di: Qi Wang, et al.
  Pubblicazione: (2024)